Alison Gartner

Alison Gartner is a Project Manager at Radiopharm Theranostics and Chimeric Therapeutics ASX: CHM. Alison is also a Board Member at the National Foundation for Medical Research and Innovation. Alison has been a Consultant at Life Sciences, helping establish new companies. Additionally, Alison is the Co-Founder of Evidentli, a software platform in digital health. With previous experience as an Investment Manager at Bioscience Managers Pty Ltd and Assistant to Director at Asia Union Investments Pty Ltd, Alison has a background in finance and asset management. Alison also has experience in sales at Westpac Financial Markets. Alison holds degrees in Biochemistry and Molecular Biology, Finance, and Economics.